Falcons' Fortunes - FACIT's Annual Pitch Competition - Tuesday, February 4, 2020
Opportunity for Ontario Cancer Researchers to vie for the
"Ernsting Entrepreneurship Award"
Falcons' Fortunes (based on the popular TV series Dragons' Den) invites Ontario-based entrepreneurs working in the oncology space to pitch innovative research ideas to an external panel of judges. Hosted by the FACIT Falcons (i.e. the FACIT team), this annual event offers $50,000 in Prospects funding to invest in the most promising oncology research idea. While the research idea should be novel and sound, the competition is for the best pitch i.e. the presentation that best convinces the investor judging panel on the value of the idea and how $50,000 would improve and/or better illustrate the potential, and if possible commercial, value of the innovative idea itself.
The Falcons’ Fortunes event endeavors to enhance, support and celebrate a culture of commercialization in Ontario, such as the cultivation of skill sets that enable ideas to be successfully pitched to investors and promotion of entrepreneurial spirit.
The Falcons’ Fortunes pitch competition is open to any Ontario-based entrepreneurial researcher (e.g. academia, research institutions, research hospitals, startups, etc.) working in the oncology space. Joint pitches from up to two researchers are also eligible. Basically, anyone with the entrepreneurial itch should participate!
How to participate:
Send an email to Lisa Milestone by Friday, November 22nd, 2019 to indicate your intent to participate. An abstract of your pitch idea must be submitted by Friday, December 6th, 2019 (instructions on submitting abstracts will be emailed to participants). A maximum of 6 participants will be selected by Thursday, December 19th, 2019 to deliver their pitches on February 4th, 2020.
Summary of Timelines:
|Notice of intent to participate - email RSVP sufficient||Fri, Nov 22|
|Submission of pitch abstracts||Fri, Dec 6|
|Announcement of selected pitch finalists||Thurs, Dec 19|
|Pitch preparation webinar||Wed, Jan 15|
|1:1 practice sessions for finalists||Mon, Jan 27|
|Falcons' Fortunes event||Tues, Feb 4|
Click here to access the registration page. Seating is limited.
Note: All audience members will be required to sign a confidentiality agreement at the time of registration. Doors will close following the keynote address.
Recognizing a real unmet need, Xpan is developing expandable surgical access ports that aim to increase safety and efficiency of minimally invasive surgeries.
ReFilx™ is a novel polymeric soft tissue filler that provides breast cancer patients with a cosmetically superior, minimally-invasive and cost-effective solution for the permanent restoration of breast defects following lumpectomy.
2017: Development of a Multi-mechanistic Vaccinia Virus-based Platform for the Treatment of Pancreatic Cancer
The novel platform delivers sustained and amplified viral-mediated cell killing specific to pancreatic cancer (PCa) via the production of PCa cell-targeted amiR-containing exosomes.
An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping improve the quality of life of bladder cancer patients.